ALICIA FOXWORTH, FNP-C
Family Nurse Practitioner · PAWLEYS ISLAND, SC
Individual Active NPI 1578110672
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 674 | 182,926 | $15,951,995 | $4,710,228 | $3,751,804 |
| 2023 | 451 | 126,059 | $9,794,005 | $3,004,998 | $2,394,431 |
| 2022 | 48 | 49 | $4,453 | $2,946 | $1,505 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J3111 | Injection, romosozumab-aqqg, 1 mg | 28,560 | $11 | $9 |
| J1306 | Injection, inclisiran, 1 mg | 24,992 | $12 | $10 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 16,500 | $22 | $17 |
| J0897 | Injection, denosumab, 1 mg | 11,280 | $26 | $21 |
| J2356 | Injection, tezepelumab-ekko, 1 mg | 9,660 | $18 | $14 |
| J2182 | Injection, mepolizumab, 1 mg | 5,400 | $30 | $24 |
| J2357 | Injection, omalizumab, 5 mg | 4,515 | $38 | $30 |
| J3245 | Injection, tildrakizumab, 1 mg | 4,000 | $135 | $107 |
| J3032 | Injection, eptinezumab-jjmr, 1 mg | 3,900 | $17 | $13 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,380 | $45 | $36 |
| J1561 | Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg | 2,360 | $48 | $39 |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 1,120 | $31 | $25 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Family Nurse Practitioner | 363LF0000X | ✓ | 25881 | SC |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- No
Other Family Nurse Practitioner providers in South Carolina
- NPI 1508441767
- NPI 1356032072
- NPI 1063738938
- NPI 1861890477
- NPI 1275115354
- NPI 1780753996
- NPI 1376297630
- NPI 1467852657
See all Family Nurse Practitioner providers in South Carolina →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.